Tower Bridge Advisors Abb Vie Inc. Transaction History

Tower Bridge Advisors

$900 Billion
Q2 2024

A detailed history of Tower Bridge Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Tower Bridge Advisors holds 38,103 shares of ABBV stock, worth $7.37 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

38,103

Previous 38,103 -0.0%

Holding current value

$7.37 Million

Previous $6.94 Billion 5.81%

% of portfolio

0.73%

Previous 0.71%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $572,635 - $652,464	-3,583 Reduced 8.6%	38,103 $6.94 Billion
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $20,915 - $23,555	-152 Reduced 0.36%	41,686 $6.46 Billion
Q3 2023 Nov 01, 2023	BUY	$133.59 - $154.65 $38,340 - $44,384	287 Added 0.69%	41,838 $6.24 Billion
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $1.83 Million - $2.28 Million	-13,848 Reduced 25.0%	41,551 $5.6 Billion
Q1 2023 Apr 26, 2023	SELL	$144.61 - $166.54 $141,717 - $163,209	-980 Reduced 1.74%	55,399 $8.83 Billion
Q4 2022 Jan 27, 2023	SELL	$138.31 - $165.87 $41,493 - $49,761	-300 Reduced 0.53%	56,379 $9.11 Billion
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $207,891 - $238,437	-1,549 Reduced 2.66%	56,679 $7.61 Billion
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $525,846 - $668,522	-3,821 Reduced 6.16%	58,228 $8.92 Billion
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $224,365 - $278,375	1,700 Added 2.82%	62,049 $10.1 Billion
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $422,951 - $535,156	-3,937 Reduced 6.12%	60,349 $8.17 Billion
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $258,764 - $293,736	2,432 Added 3.93%	64,286 $6.93 Billion
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $467,132 - $520,412	4,440 Added 7.73%	61,854 $6.97 Billion
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $381,272 - $419,734	3,727 Added 6.94%	57,414 $6.21 Billion
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $2.12 Million - $2.87 Million	26,365 Added 96.5%	53,687 $5.75 Billion
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $7,731 - $9,074	90 Added 0.33%	27,322 $2.39 Billion
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $5,135 - $6,872	-70 Reduced 0.26%	27,232 $2.67 Billion
Q1 2020 Apr 27, 2020	SELL	$64.5 - $97.79 $11,610 - $17,602	-180 Reduced 0.65%	27,302 $2.08 Billion
Q4 2019 Feb 05, 2020	BUY	$72.13 - $90.25 $25,245 - $31,587	350 Added 1.29%	27,482 $2.43 Billion
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $305,453 - $367,242	-4,850 Reduced 15.16%	27,132 $2.31 Billion
Q2 2019 Aug 06, 2019	SELL	$65.7 - $83.98 $26,280 - $33,592	-400 Reduced 1.24%	31,982 $2.33 Billion
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $310,951 - $365,974	4,031 Added 14.22%	32,382 $2.61 Billion
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $120,667 - $148,815	-1,550 Reduced 5.18%	28,351 $2.61 Billion
Q3 2018 Oct 23, 2018	SELL	$88.91 - $98.84 $128,386 - $142,724	-1,444 Reduced 4.61%	29,901 $2.83 Billion
Q2 2018 Aug 09, 2018	SELL	$89.78 - $106.23 $36,001 - $42,598	-401 Reduced 1.26%	31,345 $2.9 Billion
Q1 2018 May 02, 2018	SELL	$92.01 - $123.21 $311,637 - $417,312	-3,387 Reduced 9.64%	31,746 $3 Billion
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $3,582 - $3,928	40 Added 0.11%	35,133 $3.4 Billion
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $2.45 Million - $3.13 Million	35,093	35,093 $3.12 Billion

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Bridge Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Tower Bridge Advisors with notifications on news.

Account

Tower Bridge Advisors Abb Vie Inc. Transaction History